0

Sickle Cell Disease Treatment Market Expected to Reach $1.6 Billion by 2031—Allied Market Research

 
2022
Sickle Cell Disease Treatment Market

Report Code : A31450

quote Growth of the sickle cell disease market is driven by increase in demand for sickle cell disease treatments due to rise in prevalence of sickle cell disease and expansion of R&D pipeline, ongoing medicine approvals, and strong growth potential in unexplored new markets are expected to provide numerous opportunities for the market growth during the forecast period. quote

Onkar Sumant - Manager
Life Sciences at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

According to a new report published by Allied Market Research, titled, “Sickle Cell Disease Treatment Market," The sickle cell disease treatment market size was valued at $1.1 billion in 2021, and is estimated to reach $1.6 billion by 2031, growing at a CAGR of 4.1% from 2022 to 2031.

When a person inherits two abnormal copies of the β-globin gene (HBB), one from each parent, which produces hemoglobin “S”. This hemoglobin “S” is an abnormal form of hemoglobin causing red cells to become rigid and sickle shape. The most common type of sickle cell disease is known as sickle cell anemia. It results in an abnormality in the oxygen-carrying protein hemoglobin found in red blood cells.

The sickle cell disease treatment market growth driven by increase in prevalence of sickle cell disease, rise in pipeline products, and surge in demand for sickle cell disease drugs. In addition, expansion of R&D pipeline, ongoing medicine approvals, and strong growth potential in unexplored new markets are expected to provide numerous sickle cell disease treatment market opportunity for the market growth during the forecast period. For instance, in November 2019, FDA approved Oxbryta (voxeletor), to treat the sickle cell disease, which is expected to boost the market growth.

Moreover, increase in initiatives taken by government of various countries for promoting access programmes and expanding distribution network for sickle cell disease drugs are some sickle cell disease treatment market trends contribute toward the growth of the market. For instance, Emmaus announced the agreement with Mc Kesson Plasma and Biologics LLC. to expand the distribution network of Endari for sickle cell disease patients.

The outbreak of COVID-19 has resulted in a significant decline in demand for sickle cell disease treatments across several sectors, particularly the health and pharmaceutical sector. Factors such as decline in hospitalizations, ER visits, duration of stay, and decrease in people who receive routine follow-up care from a hematologist restraint the sickle cell disease treatment industry during COVID-19.

The sickle cell disease treatment market size is segmented on the basis of drug type, type, route of administration, and region. By drug type, the market is segmented into hydroxyurea, oxbryta, adakveo and others. The others segment further includes, Endari, pain-relieving medication, and others. The hydroxyurea segment exhibited highest growth in 2021, owing to high adoption of hydroxyurea due to rise in prevalence of sickle cell disease.

On the basis of type, the market is segmented into sickle cell anemia or HbSS, HbSC, and others. The others segment further includes, HbS beta thalassemia, HbSD, HbSE, and HbSO. The sickle cell anemia segment exhibited highest sickle cell disease treatment market share in 2021, and is expected to remain dominant during the forecast period, owing to increase in prevalence of sickle cell anemia. For instance, according to National Library of Medicine (NIH), the annual number of newborns with sickle cell anemia is estimated to exceed 400,000 by 2050.

On the basis of route of administration, the market is segmented into oral and parenteral. The oral segment dominated the market in 2021. This was attributed to advantages associated with oral route, such as more pre-determined doses, convenient to administer drug, and patient self-administration. In addition, oral route is most preferred due to its cost effectiveness and strong patient compliance, which further fuels the segment growth.

North America accounted for the largest sickle cell disease treatment market share of the global sickle cell disease market in 2021, owing to factors such as availability of treatments for sickle cell disease, well-established regulations for approval and distribution of products & services. 

However, Asia-Pacific is expected to fastest CAGR during the sickle cell disease treatment market analysis, owing to increase in cases of sickle cell disease. Moreover, growth in investments for development of advanced treatment for sickle cell disease is the key driving factor that boosts the growth of the market in the region.

KEY FINDINGS OF THE STUDY 
 
Based on drug type, the hydroxyurea segment held largest share in the global sickle cell disease treatment industry in 2021.
• On the basis of type, the sickle cell anemia segment held largest market share in 2021, and is expected to continue this trend during the forecast period.
• Based on route of administration, oral segment dominated the market in 2021. However, parenteral segment is expected to grow at a CAGR of 4.3% during the forecast period.
• On the basis of region, North America held largest share in the global market in 2021. However, Asia-Pacific is anticipated to grow at the highest CAGR of 5.7% during the forecast period.

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
 
 

First time buyer?
Check offers and discount on this report
To get this report

Click Here
 
 

quote Sickle Cell Disease Treatment Market by Drug Type (Hydroxyurea, Oxybryta, Adakveo, Others), by Type (Sickle Cell Anemia, HbSC, Others), by Route of Administration (Oral, Parenteral): Global Opportunity Analysis and Industry Forecast, 2021-2031 quote

View Report
 
 

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 2,000 niche industries and company profiles on more than 12,000 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.

 
 

WHY ALLIED MARKET RESEARCH?

INFLALLIBLE METHODOLOGY

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

ANALYST SUPPORT

For complete satisfaction

CUSTOMIZATION

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 
rep-img

Published Date May 2024

FMCG Packaging Market

Download Sample
rep-img

Published Date May 2024

Pet Insurance Market

Download Sample

Buy Full Version
"Sickle Cell Disease Treatment Market"
Purchase Enquiry

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers